In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Diazinon Drug Master File in Korea (Diazinon KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Diazinon. The MFDS reviews the Diazinon KDMF as part of the drug registration process and uses the information provided in the Diazinon KDMF to evaluate the safety and efficacy of the drug.
After submitting a Diazinon KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Diazinon API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Diazinon suppliers with KDMF on PharmaCompass.